Palliative Lattice Stereotactic Body Radiotherapy (SBRT) for Patients With Sarcoma, Thoracic, Abdominal, and Pelvic Cancers
NCT04553471 is an interventional trial sponsored by Washington University School of Medicine. As of 21 Nov 2026, it is completed. It studies Abdominal Cancer, Pelvic Cancer and 2 more conditions. The registry lists an enrollment of 70 participants at 1 site in 1 country. The registry lists a start date of 22 Sept 2020 and a primary completion date of 30 Sept 2022. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04553471 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Washington University School of Medicine |
| Enrollment | 70 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Abdominal Cancer, Pelvic Cancer, Sarcoma and Thoracic Cancer |
| Start | 22 Sept 2020 |
| Primary completion | 30 Sept 2022 |
| Study completion | 4 May 2023 |
| Last update posted | 29 Aug 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Washington University School of Medicine
St Louis
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04553471
Each answer restates registry values shown on this page.
What is NCT04553471?
NCT04553471 is an interventional trial sponsored by Washington University School of Medicine. It studies Abdominal Cancer, Pelvic Cancer and 2 more conditions.
Who leads NCT04553471?
The registry names Pamela Samson, M.D. (principal investigator, Washington University School of Medicine) as the overall official.
Where does NCT04553471 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT04553471 end?
The registry lists a primary completion date of 30 Sept 2022 and a study completion date of 4 May 2023. The sponsor last updated the record on 29 Aug 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.